Auven Therapeutics Revenue and Competitors

Saint Thomas, USA

Location

$100M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Auven Therapeutics's estimated annual revenue is currently $930k per year.(i)
  • Auven Therapeutics's estimated revenue per employee is $77,500
  • Auven Therapeutics's total funding is $100M.

Employee Data

  • Auven Therapeutics has 12 Employees.(i)
  • Auven Therapeutics grew their employee count by 0% last year.

Auven Therapeutics's People

NameTitleEmail/Phone
1
Chief Accounting OfficerReveal Email/Phone
2
Head ITReveal Email/Phone
3
Managing Director, Intellectual Property & LicensingReveal Email/Phone
4
Director Investor Relations and Public RelationsReveal Email/Phone
5
Group Controller & Bermuda Branch Manager Reveal Email/Phone
6
Co-Founder and Managing General PartnerReveal Email/Phone
7
Managing Director, Investments & Business Development, US Reveal Email/Phone
8
Managing Dir Investments & Business Development, EuropeReveal Email/Phone
9
Corporate CounselReveal Email/Phone
10
Managing Dir, Head Clinical DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$10.1M655%N/AN/A
#10
$16.1M1049%N/AN/A
Add Company

What Is Auven Therapeutics?

Auven Therapeutics is an investment advisor with its principal place of business in the US Virgin Islands. It manages Auven Therapeutics Holdings L.P., a private equity fund, which has its registered office and principal place of business in the British Virgin Islands. Auven Therapeutics Development, the operating company of Auven Therapeutics Management L.L.L.P. Holdings L.P. manages drug development from its bases in Lausanne, Switzerland, New York, USA and Hamilton, Bermuda

keywords:N/A

$100M

Total Funding

12

Number of Employees

$930k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Auven Therapeutics News

2022-04-17 - Dry Eye Syndrome Treatment Market Incredible Possibilities, Growth ...

Auven Therapeutics; Akorn; Bausch Lomb; Alimera; GlaxoSmithKline. Segmentation. This study includes all forms of segmentation from the region:...

2022-04-17 - Dry Eye Syndrome Market Size And Forecast | Bausch + Lomb ...

Ltd, Auven Therapeutics, GlaxoSmithKline plc, Nicox S.A., Otsuka Holdings Co. Ltd. The report provides a good overview of the key...

2022-04-17 - Global Allergic Conjunctivitis Market Dynamics Analysis, Production ...

... Sirion Therapeutics; Boehringer Ingelheim; Atopix Therapeutics; Laila Pharmaceuticals; Laboratoires Thea; Auven Therapeutics.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.5M797%N/A